SKERT, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 549
EU - Europa 168
AS - Asia 94
Totale 811
Nazione #
US - Stati Uniti d'America 547
CN - Cina 60
IT - Italia 45
UA - Ucraina 42
HK - Hong Kong 22
DE - Germania 21
FI - Finlandia 17
IE - Irlanda 12
BE - Belgio 11
SE - Svezia 9
GB - Regno Unito 8
SG - Singapore 4
IN - India 3
TR - Turchia 3
FR - Francia 2
CA - Canada 1
GR - Grecia 1
IR - Iran 1
JO - Giordania 1
MX - Messico 1
Totale 811
Città #
Fairfield 80
Chandler 52
Ann Arbor 50
Ashburn 45
Cambridge 43
Seattle 42
Jacksonville 35
Houston 33
Woodbridge 32
New York 26
Wilmington 24
Beijing 23
Hong Kong 22
Princeton 20
Helsinki 16
Brescia 13
Brussels 11
Dublin 10
Shanghai 6
Des Moines 4
Jinan 4
Nanjing 4
San Diego 4
Guangzhou 3
Hangzhou 3
Hebei 3
Shenyang 3
Tianjin 3
Boardman 2
Changsha 2
Dearborn 2
Kocaeli 2
Ningbo 2
Pune 2
Amman 1
Ardabil 1
Codogno 1
Jiaxing 1
Kilburn 1
Kunming 1
Lappeenranta 1
Los Angeles 1
Mexico City 1
Nanchang 1
Orange 1
Porto 1
Redmond 1
San Francisco 1
Stockholm 1
Toronto 1
Totale 642
Nome #
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 131
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 116
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 112
Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System 104
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 79
Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor? 69
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 62
Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis 47
EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS. 47
GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIENTS AGED OVER 60 FROM 2000 TO 2017. IMPROVEMENTS AND CRITICISMS 40
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study 13
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 9
Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients 4
Totale 833
Categoria #
all - tutte 4.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 20 19
2019/2020201 20 9 4 14 9 15 18 15 27 40 10 20
2020/2021197 4 18 5 36 6 29 9 23 13 29 14 11
2021/2022116 10 4 0 8 9 17 5 6 4 24 6 23
2022/2023120 18 3 6 14 13 25 0 14 21 0 2 4
2023/2024125 12 2 19 5 7 35 9 7 27 2 0 0
Totale 833